Heart rate drug may reveal why exercise gets harder with age

NCT ID NCT07717710

First seen Jul 21, 2026 · Last updated Jul 23, 2026 · Updated 2 times

Summary

This study tests whether ivabradine, a medication that slows heart rate without weakening the heart's pumping strength, can help researchers understand how heart rate limits exercise capacity. Healthy younger and older adults will take a single dose of ivabradine before cycling tests to measure heart rate and work rate. The goal is to learn why the heart's ability to pump blood plateaus during exercise, which may explain age-related declines in exercise tolerance.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ivabradine (a heart-rate-lowering medication)
What this could lead to
If successful, this study could clarify how heart rate affects the heart's ability to supply oxygen during exercise, potentially informing treatments for age-related exercise limitations.
What could go wrong
This is a small, early-phase pilot study in healthy volunteers, so results may not apply to people with heart conditions. Side effects like slow heart rate, visual symptoms, and headache are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY ADULT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • SportsCardiologyBC, UBC Hospital

    Vancouver, British Columbia, V6T 2B5, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.